LAKE FOREST, Ill., Feb. 18, 2016 -- Stericycle, Inc. (NASDAQ:SRCL) today announced that its board of directors has declared a dividend of $13.125 per share on the company’s 5.25% Series A Mandatory Convertible Preferred Stock, to be paid in cash on March 15, 2016 to holders of record as of March 1, 2016. This equates to $1.3125 per depositary share, each of which represents a 1/10th interest in a share of the mandatory convertible preferred stock.
About Stericycle, Inc.
Stericycle, Inc., a U.S.-based business-to-business services company operating in 23 countries, is focused on solutions that protect people and brands, promote health and safeguard the environment. For more information about Stericycle, please visit our website at www.stericycle.com.
Safe Harbor Statement: This press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic and market conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of the collection, transportation, treatment and disposal of regulated waste or the proper handling and protection of personal and confidential information, increases in transportation and other operating costs, the level of governmental enforcement of regulations governing regulated waste collection and treatment or the proper handling and protection of personal and confidential information, our obligations to service our substantial indebtedness and to comply with the covenants and restrictions contained in our private placement notes, term loan credit facility and revolving credit facility, our ability to execute our acquisition strategy and to integrate acquired businesses, competition and demand for services in the regulated waste and secure information destruction industries, political, economic and currency risks related to our foreign operations, impairments of goodwill or other indefinite-lived intangibles, variability in the demand for services we provide on a project or non-recurring basis, exposure to environmental liabilities, fluctuations in the price we receive for the sale of paper, disruptions in or attacks on our information technology systems, compliance with existing and future legal and regulatory requirements, as well as other factors described in our filings with the U.S. Securities and Exchange Commission, including our most recently filed Annual Report on Form 10-K. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.
CONTACT: Stericycle Investor Relations (847) 607-2012


DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
Google Secures Pentagon AI Deal for Classified Projects
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO 



